Related Experiment Video
Updated: Aug 8, 2026
Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
Published on: November 17, 2014
Explorative study of interleukin levels in the human cornea
Insights
Interleukin levels in human corneas are higher in inflammatory conditions like keratitis and ulcerations. Measuring these interleukin-1 beta and interleukin-6 levels can help evaluate corneal inflammation.
Area of Science:
- Ophthalmology
- Immunology
- Corneal Disease Research
Background:
- Interleukins are present in ocular tissues and implicated in corneal inflammatory disorders.
- Pathogenic mechanisms involving interleukins in corneal inflammation are not fully understood.
- This study investigates interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) concentrations in human corneas.
Purpose of the Study:
- To analyze the concentrations of IL-1 beta and IL-6 in human corneas.
- To correlate interleukin levels with various clinical diagnoses of corneal diseases.
- To assess the potential of interleukin levels as biomarkers for corneal inflammation.
Main Methods:
- 127 explanted human corneas with diverse corneal diseases were collected post-keratoplasty.
- Corneal tissues were snap-frozen, cryosectioned, and histologically examined.
- Protein content was measured (Bradford method), and IL-1 beta and IL-6 concentrations were determined via ELISA.
Main Results:
- Elevated levels of IL-1 beta and IL-6 were observed in corneas exhibiting ulcerations and significant inflammatory signs.
- Lower concentrations of both interleukins were detected in corneas with minimal inflammatory indicators.
- A clear distinction in interleukin levels was found between inflammatory and non-inflammatory corneal conditions.
Conclusions:
- Higher interleukin levels were associated with inflammatory conditions such as keratitis, inflammatory keratoconus, and ulcerating processes.
- Non-inflammatory corneal disorders, including scars, dystrophies, and non-inflammatory keratoconus, showed lower interleukin levels.
- Corneal interleukin levels can potentially serve as indicators for evaluating the inflammatory status based on clinical diagnosis.
Background:
The presence of interleukins has been demonstrated in the cornea and other ocular tissues. Although pathogenic mechanisms are unknown, interleukins seem to be involved in inflammatory disorders of the cornea. The present study was undertaken to analyse concentrations of interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) in human corneas with various clinical diagnoses.
Methods:
Immediately after keratoplasty 127 explanted human corneas with various corneal diseases were snap frozen and cryosections were prepared for histological examination. Furthermore, the protein content was measured according to the method of Bradford and the concentration of IL-1 beta and IL-6 were determined using a specific immunosorbent test (ELISA).
Results:
It was found that IL-1 beta and IL-6 level were clearly higher in corneas with ulcerations and distinct inflammatory signs. Lower levels of both interleukins were found in corneas with a weak expression of inflammatory signs.
Conclusions:
Keratitis, keratoconus with inflammatory signs, and ulcerating processes showed higher interleukin levels than corneas with non-inflammatory disorders like scar formation, corneal dystrophy and keratoconus. The results could show that, depending on the clinical diagnosis, the inflammatory status of the cornea may be evaluated by the interleukin levels determined in the corneal tissue.
